QuintilesIMS
 | |
| Public | |
| Traded as |
NYSE: Q Russell 2500 Component |
| Industry |
Contract Research Organization Pharmaceutical Service Consulting |
| Founded | 1982 |
| Headquarters | Durham, North Carolina, USA |
Key people |
Dennis Gillings, Founder Ari Bousbib, Chairman and CEO |
| Products | Support services for pharmaceutical, biotech and medical companies and individuals |
| Revenue |
 US$ $6.878 billion (2016)[1] |
Number of employees | ~ 50,000 (2017) |
| Website | http://www.quintilesims.com/ |
Quintiles IMS Holdings, Inc., branded as QuintilesIMS[2] is an American multinational company serving the combined industries of health information technologies and clinical research. It is a Fortune 500 company and the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 50,000 employees conducting business in approximately 100 countries.[2]
QuintilesIMS is the world’s largest contract research organization[3] as ranked by reported service revenues, and is focused primarily on Phase II-IV clinical trials and associated laboratory and analytical services.
History
- In 1982, Dennis Gillings founded and incorporated Quintiles Transnational in North Carolina.[4]
- Quintiles Transnational established Quintiles Pacific Inc. and Quintiles Ireland Ltd. in 1990,[5] and in 1991 Quintiles GmbH was established in Germany and Quintiles Laboratories Ltd. was established in Atlanta, Georgia.[6]
- In September 1996, Quintiles purchased Innovex Ltd. of Britain for $747.5 million in stock.[7]
- Quintiles went public in 1997 and completed a successful secondary stock offering.[8]
- Over 2016 concluding on October 3, Quintiles underwent a $17.6 billion merger with IMS Health becoming QuintilesIMS.[2][9]
References
- ↑ Fortune 500
- 1 2 3 Smith, Rick. "Quintiles, IMS Health complete $17B merger; no word on any job cuts". WRAL Techwire, Capitol Broadcasting Corporation, Inc. Retrieved 2016-10-04.
- ↑ "Inside Quintiles: The World's Largest CRO". Outsourcing-Pharma.com.
- ↑ Matthew Herper (November 22, 2010). "Money, Math and Medicine". Forbes Magazine. Retrieved July 21, 2011.
- ↑ "Quintiles Pacific, Inc.: Private Company Information - Businessweek".
- ↑ "Quintiles Laboratories Limited: Private Company Information - Businessweek".
- ↑ Derdak T, Atkins, W (2005). "Quintiles Transnational Corp". Encyclopedia.com.
- ↑ Olivia Oran (9 May 2013). "Quintiles IPO raises more-than-planned $947 million as stocks rally". Reuters.
- ↑ Henderson, Jennifer (3 October 2016). "Quintiles, IMS Health complete merger". Triangle Business Journal, American City Business Journals. Retrieved 3 October 2016.
External links
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.